Latest news with #TruistFinancial
Yahoo
12 hours ago
- Business
- Yahoo
Truist Financial Stock: Is Wall Street Bullish or Bearish?
Truist Financial Corporation (TFC), headquartered in Charlotte, North Carolina, is a leading financial services provider specializing in banking and trust services. Valued at $58.6 billion by market cap, the company provides a diverse array of services, encompassing retail, small business, and commercial banking, asset management, capital markets, commercial real estate, corporate and institutional banking, insurance, mortgage, payments, and specialized lending and wealth management solutions. Shares of this leading commercial bank have underperformed the broader market over the past year. TFC has declined 1.5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 17%. In 2025, TFC stock is up 2%, compared to SPX's 8.2% rise on a YTD basis. More News from Barchart Morgan Stanley Says Nvidia Has 'Exceptional' Strength. Should You Buy NVDA Stock Here? Dear MicroStrategy Stock Fans, Mark Your Calendars for July 31 2 Growth Stocks Wall Street Predicts Will Soar 74% to 159% Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Narrowing the focus, TFC's underperformance is also apparent compared to the SPDR S&P Regional Banking ETF (KRE). The exchange-traded fund has gained about 3.9% over the past year. However, TFC's single-digit returns on a YTD basis outshine the ETF's marginal gains over the same time frame. TFC's underperformance is due to higher net interest income and total non-interest income, as well as lower expenses. Additionally, elevated expenses and weak asset quality in a challenging operating environment pose significant challenges for the company. On Jul. 18, TFC shares closed down more than 1% after reporting its Q2 results. Its adjusted EPS of $0.91 missed the consensus estimate by a penny. The company's total revenues were $4.99 billion, marginally beating the consensus estimate of $4.98 billion. For the current fiscal year, ending in December, analysts expect TFC's EPS to grow 4.3% to $3.85 on a diluted basis. The company's earnings surprise history is mixed. It beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion. Among the 22 analysts covering TFC stock, the consensus is a 'Moderate Buy.' That's based on nine 'Strong Buy' ratings, two 'Moderate Buys,' 10 'Holds,' and one 'Strong Sell.' This configuration is more bullish than two months ago, with eight analysts suggesting a 'Strong Buy.' On Jul. 21, Morgan Stanley (MS) kept an 'Equal Weight' rating on TFC and raised the price target to $48, implying a potential upside of 8.4% from current levels. The mean price target of $48.86 represents a 10.4% premium to TFC's current price levels. The Street-high price target of $55 suggests an upside potential of 24.2%. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
2 days ago
- Business
- Business Insider
Incyte (INCY) Gets a Hold from Truist Financial
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Hold rating on Incyte, with a price target of $79.00. The company's shares closed today at $77.38. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Devarakonda covers the Healthcare sector, focusing on stocks such as Scholar Rock Holding, Incyte, and Nurix Therapeutics. According to TipRanks, Devarakonda has an average return of 0.4% and a 44.12% success rate on recommended stocks. In addition to Truist Financial, Incyte also received a Hold from William Blair's Matt Phipps in a report issued today. However, on the same day, TD Cowen maintained a Buy rating on Incyte (NASDAQ: INCY). The company has a one-year high of $83.95 and a one-year low of $53.56. Currently, Incyte has an average volume of 1.83M. Based on the recent corporate insider activity of 90 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of INCY in relation to earlier this year. Earlier this month, Steven H Stein, the EVP & Chief Medical Officer of INCY sold 3,706.00 shares for a total of $251,785.64.
Yahoo
4 days ago
- Business
- Yahoo
Lantheus Holdings Expands Alzheimer's Diagnostics Despite Recent Stock Dip
Lantheus Holdings, Inc. (NASDAQ:LNTH) is one of the . The company completes the acquisition of Life Molecular Imaging Limited amid a fall in the monthly and weekly performance of shares. A medical professional performing a pulmonary function assessment on a patient. Lantheus Holdings, Inc. (NASDAQ:LNTH) is a Massachusetts-based company specializing in radiopharmaceuticals and diagnostic imaging. Through Lantheus Medical Imaging, Progenics, and EXINI, the company develops and commercializes precision diagnostics and radiotherapeutics used in oncology and cardiology. It is supported by strategic partnerships from global healthcare leaders. On July 21, 2025, Lantheus Holdings, Inc. (NASDAQ:LNTH) announced the completion of the acquisition of Life Molecular Imaging Limited. With the $350 million acquisition and the addition of Neuraceq, an F-18 PET imaging agent, Lantheus Holdings, Inc. (NASDAQ:LNTH) increases its capabilities in Alzheimer's disease diagnostics. On the other hand, the company's weekly and monthly performance were down by 10.98% and 8.65%, respectively. These declines follow the expiration of the company's transitional pass-through payment status for its product PYLARIFY and the subsequent implementation of the mean unit cost pricing for Medicare fee-for-service coverage. However, analysts, including Truist Financial and TD Cowen, stick to their Buy rating on the stock, signaling confidence in the company's future growth. Lantheus Holdings, Inc. (NASDAQ:LNTH) is anticipated to incur an 8.36% EPS growth in the next 5 years, and it currently has a low beta of 0.15, which makes the stock a good buy for investors seeking long term stocks with low risks. While we acknowledge the potential of LNTH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025 Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22-07-2025
- Business
- Yahoo
Raymond James Cuts Truist Financial (TFC) PT, Keeps Outperform Rating
Truist Financial Corporation (NYSE:TFC) is one of the 10 Best Financial Stocks on Wall Street's Radar. On July 18, Raymond James reduced its price target for Truist Financial Corporation (NYSE:TFC) from $50 to $48 while keeping an 'Outperform' rating. The investment firm noted that Truist Financial Corporation (NYSE:TFC) shares are underperforming. Raymond James believes this reflects market concerns around near-term net interest margin/net interest income and the expected increase in investment banking fees in the second half of the year. A closeup view of a hand inserting a credit card into an ATM machine. The firm now projects adjusted revenue growth for Truist Financial Corporation (NYSE:TFC) to be at the low end of the company's own target range of 1.5% to 2.5%. This view reflects the uncertain business and economic environment. However, Raymond James noted that if there is progress on deregulation and loan growth improves, Truist Financial Corporation (NYSE:TFC) could see stronger results. The investment firm still believes there is a 'modestly positive risk-reward skew' for Truist Financial Corporation (NYSE:TFC). Raymond James pointed to the company's progress toward mid-teens return on tangible common equity, a slight improvement in the short-term outlook for credit, and expected positive operating leverage. All of this comes as Truist Financial Corporation (NYSE:TFC) trades at a discount compared to its peers. Truist Financial Corporation (NYSE:TFC) is an American bank holding and financial services company. It specializes in consumer and small business banking, commercial banking, corporate and investment banking, wealth management, payments, and specialized lending businesses. While we acknowledge the potential of TFC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
19-07-2025
- Business
- Business Insider
Stephens Sticks to Their Buy Rating for Truist Financial (TFC)
Stephens analyst Terry McEvoy maintained a Buy rating on Truist Financial yesterday and set a price target of $49.00. The company's shares closed yesterday at $44.25. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, McEvoy is a 4-star analyst with an average return of 7.7% and a 61.09% success rate. McEvoy covers the Financial sector, focusing on stocks such as Truist Financial, Regions Financial, and Associated Banc-Corp. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Truist Financial with a $47.07 average price target, implying a 6.37% upside from current levels. In a report released on July 13, Bank of America Securities also maintained a Buy rating on the stock with a $50.00 price target. The company has a one-year high of $49.06 and a one-year low of $33.56. Currently, Truist Financial has an average volume of 7.89M.
